MOESM2 of Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Pavlů, Jiří; Labopin, Myriam; Niittyvuopio, Riitta; Socié, Gerard; Yakoub-Agha, Ibrahim; Wu, Depei; Remenyi, Peter; Passweg, Jakob; Beelen, Dietrich; Aljurf, Mahmoud; Kröger, Nicolaus; Labussière-Wallet, Hélène; Perić, Zinaida; Giebel, Sebastian; Nagler, Arnon; Mohty, Mohamad

doi:10.6084/m9.figshare.10033697.v1

13045_2019_790_MOESM2_ESM.docx (41.85 kB)

MOESM2 of Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

journal contribution

posted on 2019-10-24, 12:26 authored by Jiří Pavlů, Myriam Labopin, Riitta Niittyvuopio, Gerard Socié, Ibrahim Yakoub-Agha, Depei Wu, Peter Remenyi, Jakob Passweg, Dietrich Beelen, Mahmoud Aljurf, Nicolaus Kröger, Hélène Labussière-Wallet, Zinaida Perić, Sebastian Giebel, Arnon Nagler, Mohamad Mohty

Additional file 2. Univariate analysis of factors determining outcomes of transplantation at 2 years.

Funding

National Institute for Health Research Biomedical Research Centre based at Imperial College London

History

Usage metrics

Keywords

Measurable residual disease Allogeneic hematopoietic cell transplantation Acute lymphoblastic leukemia Allogeneic Myeloablative conditioning Total body irradiation

Licence

CC BY + CC0

MOESM2 of Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Funding

National Institute for Health Research Biomedical Research Centre based at Imperial College London

History

Usage metrics

Categories

Keywords

Licence

Exports